enGene Holdings Inc. Warrants
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGen… Read more
enGene Holdings Inc. Warrants (ENGNW) - Net Assets
Latest net assets as of October 2025: $167.71 Million USD
Based on the latest financial reports, enGene Holdings Inc. Warrants (ENGNW) has net assets worth $167.71 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($221.47 Million) and total liabilities ($53.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $167.71 Million |
| % of Total Assets | 75.73% |
| Annual Growth Rate | 7.12% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 132.39 |
enGene Holdings Inc. Warrants - Net Assets Trend (2021–2025)
This chart illustrates how enGene Holdings Inc. Warrants's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for enGene Holdings Inc. Warrants (2021–2025)
The table below shows the annual net assets of enGene Holdings Inc. Warrants from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-10-31 | $167.71 Million | -38.48% |
| 2024-10-31 | $272.61 Million | +276.09% |
| 2023-10-31 | $72.49 Million | -43.11% |
| 2022-10-31 | $127.42 Million | +0.02% |
| 2021-10-31 | $127.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to enGene Holdings Inc. Warrants's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 36975367800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (October 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $513.28 Million | 306.05% |
| Other Comprehensive Income | $-888.00K | -0.53% |
| Other Components | $27.35 Million | 16.31% |
| Total Equity | $167.71 Million | 100.00% |
enGene Holdings Inc. Warrants Competitors by Market Cap
The table below lists competitors of enGene Holdings Inc. Warrants ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
King Core Electronics Inc
TW:6155
|
$73.23 Million |
|
Chung Lien Transportation Co Ltd
TWO:5604
|
$73.28 Million |
|
CleanSpark, Inc. Warrant
NASDAQ:CLSKW
|
$73.28 Million |
|
Akebono Brake Industry Co. Ltd
PINK:AKBIF
|
$73.29 Million |
|
Mogan Enerji Yatırım Holding As
IS:MOGAN
|
$73.20 Million |
|
Hope Education Group Co. Ltd
F:HE1
|
$73.18 Million |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
$73.17 Million |
|
Sri Rejeki Isman(Sritex)PT
JK:SRIL
|
$73.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in enGene Holdings Inc. Warrants's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 272,612,000 to 167,710,000, a change of -104,902,000 (-38.5%).
- Net income of 117,302,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 531,000.
- Other factors decreased equity by 222,735,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $117.30 Million | +69.94% |
| Other Comprehensive Income | $531.00K | +0.32% |
| Other Changes | $-222.74 Million | -132.81% |
| Total Change | $- | -38.48% |
Book Value vs Market Value Analysis
This analysis compares enGene Holdings Inc. Warrants's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.68x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.28x to 0.68x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-10-31 | $8.06 | $2.23 | x |
| 2022-10-31 | $8.06 | $2.23 | x |
| 2023-10-31 | $3.08 | $2.23 | x |
| 2024-10-31 | $6.11 | $2.23 | x |
| 2025-10-31 | $3.28 | $2.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently enGene Holdings Inc. Warrants utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 69.94%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.32x
- Recent ROE (69.94%) is above the historical average (-21.30%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -18.40% | 0.00% | 0.00x | 1.03x | $-36.18 Million |
| 2022 | 0.02% | 0.00% | 0.00x | 1.04x | $-12.71 Million |
| 2023 | -137.84% | 0.00% | 0.00x | 1.20x | $-107.17 Million |
| 2024 | -20.23% | 0.00% | 0.00x | 1.14x | $-82.40 Million |
| 2025 | 69.94% | 0.00% | 0.00x | 1.32x | $100.53 Million |
Industry Comparison
This section compares enGene Holdings Inc. Warrants's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| enGene Holdings Inc. Warrants (ENGNW) | $167.71 Million | -18.40% | 0.32x | $73.21 Million |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |